Hi @dachopper,
agree, that was the point I was discussing with @irenekwshiu yesterday.
I'm checking in searches for MSB commentary on e.g. CRO engagement under contract (which would need a draft trial protocol speccing the RYONCIL product as an annexure, IMO) or a similar inflection-point confirmation by other players in BMT CTN regarding trial steps underway. And apart from MSB, of course, I think that could come from any of Emmes Company (if they're being used as CRO), or Medical College of Wisconsin or NMDP, but it should also appear very early IMO on the BMT CTN site itself. Link here.
Cheers
GLTA(LT)H
Hi @dachopper, agree, that was the point I was discussing with...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.78 |
Change
0.255(16.7%) |
Mkt cap ! $2.032B | |||
| Open | High | Low | Value | Volume |
| $1.74 | $1.83 | $1.71 | $27.76M | 15.59M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 30000 | $1.78 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.79 | 48074 | 4 |
View Market Depth
| Last trade - 16.10pm 14/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |